CN1028990C - 抑制人体免疫缺乏病毒的苯乙酰胺衍生物的制备方法 - Google Patents

抑制人体免疫缺乏病毒的苯乙酰胺衍生物的制备方法 Download PDF

Info

Publication number
CN1028990C
CN1028990C CN91105305A CN91105305A CN1028990C CN 1028990 C CN1028990 C CN 1028990C CN 91105305 A CN91105305 A CN 91105305A CN 91105305 A CN91105305 A CN 91105305A CN 1028990 C CN1028990 C CN 1028990C
Authority
CN
China
Prior art keywords
compound
hydrogen
formula
parts
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN91105305A
Other languages
English (en)
Chinese (zh)
Other versions
CN1058958A (zh
Inventor
G·H·P·范达埃勒
M·G·C·韦尔东克
J·P·R·M·A·博斯曼斯
P·A·J·扬森
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceutica NV
Original Assignee
Janssen Pharmaceutica NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica NV filed Critical Janssen Pharmaceutica NV
Publication of CN1058958A publication Critical patent/CN1058958A/zh
Application granted granted Critical
Publication of CN1028990C publication Critical patent/CN1028990C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C327/00—Thiocarboxylic acids
    • C07C327/38—Amides of thiocarboxylic acids
    • C07C327/40—Amides of thiocarboxylic acids having carbon atoms of thiocarboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C327/44—Amides of thiocarboxylic acids having carbon atoms of thiocarboxamide groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of an unsaturated carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/45—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by at least one doubly—bound oxygen atom, not being part of a —CHO group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/49—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups
    • C07C205/57—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/20—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
    • C07C237/30—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having the nitrogen atom of the carboxamide group bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
    • C07C237/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/32—Oximes
    • C07C251/34—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C251/48—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with the carbon atom of at least one of the oxyimino groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/72—Hydrazones
    • C07C251/86—Hydrazones having doubly-bound carbon atoms of hydrazone groups bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/32—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
    • C07C255/42—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by singly-bound nitrogen atoms, not being further bound to other hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/57—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and carboxyl groups, other than cyano groups, bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/004—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reaction with organometalhalides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/80—Ketones containing a keto group bound to a six-membered aromatic ring containing halogen
    • C07C49/813—Ketones containing a keto group bound to a six-membered aromatic ring containing halogen polycyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • AIDS & HIV (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
CN91105305A 1990-07-10 1991-07-10 抑制人体免疫缺乏病毒的苯乙酰胺衍生物的制备方法 Expired - Fee Related CN1028990C (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP90201857 1990-07-10
EP90201857.1 1990-07-10
EP91200646 1991-03-22
EP91200646.7 1991-03-22

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CN94117208A Division CN1033142C (zh) 1990-07-10 1994-10-25 具有抗人体免疫缺乏病毒的药物组合物的制备方法

Publications (2)

Publication Number Publication Date
CN1058958A CN1058958A (zh) 1992-02-26
CN1028990C true CN1028990C (zh) 1995-06-21

Family

ID=26125946

Family Applications (2)

Application Number Title Priority Date Filing Date
CN91105305A Expired - Fee Related CN1028990C (zh) 1990-07-10 1991-07-10 抑制人体免疫缺乏病毒的苯乙酰胺衍生物的制备方法
CN94117208A Expired - Fee Related CN1033142C (zh) 1990-07-10 1994-10-25 具有抗人体免疫缺乏病毒的药物组合物的制备方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN94117208A Expired - Fee Related CN1033142C (zh) 1990-07-10 1994-10-25 具有抗人体免疫缺乏病毒的药物组合物的制备方法

Country Status (42)

Country Link
US (2) US5556886A (enExample)
EP (1) EP0538301B1 (enExample)
JP (1) JPH0819068B2 (enExample)
KR (1) KR0183446B1 (enExample)
CN (2) CN1028990C (enExample)
AP (1) AP311A (enExample)
AT (1) ATE144765T1 (enExample)
AU (1) AU643056B2 (enExample)
BG (1) BG61809B1 (enExample)
CA (1) CA2084508A1 (enExample)
CZ (1) CZ279901B6 (enExample)
DE (1) DE69122963T2 (enExample)
DK (1) DK0538301T3 (enExample)
DZ (1) DZ1514A1 (enExample)
ES (1) ES2095942T3 (enExample)
FI (1) FI930070A7 (enExample)
GR (1) GR3021829T3 (enExample)
HR (1) HRP930485A2 (enExample)
HU (2) HUT64013A (enExample)
IE (1) IE75693B1 (enExample)
IL (3) IL98756A (enExample)
LT (1) LT3602B (enExample)
LV (1) LV10086B (enExample)
MA (1) MA22208A1 (enExample)
MX (1) MX9100100A (enExample)
MY (1) MY108580A (enExample)
NO (1) NO303777B1 (enExample)
NZ (1) NZ238763A (enExample)
OA (1) OA09770A (enExample)
PH (1) PH30977A (enExample)
PL (1) PL167076B1 (enExample)
PT (1) PT98259B (enExample)
RO (1) RO112855B1 (enExample)
RU (1) RU2087465C1 (enExample)
SG (1) SG48829A1 (enExample)
SI (1) SI9111204A (enExample)
SK (1) SK279639B6 (enExample)
TN (1) TNSN91056A1 (enExample)
TW (1) TW204337B (enExample)
WO (1) WO1992000952A1 (enExample)
YU (1) YU120491A (enExample)
ZA (1) ZA915334B (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0620809B1 (en) * 1991-12-30 1997-03-05 Janssen Pharmaceutica N.V. $g(a)-SUBSTITUTED BENZENEMETHANAMINE DERIVATIVES
US6177435B1 (en) 1992-05-13 2001-01-23 Glaxo Wellcome Inc. Therapeutic combinations
DE69303996T2 (de) * 1992-07-06 1997-02-27 American Cyanamid Co o-Nitrophenyl Cyclopropyl Keton, herbizides Zwischenprodukt und Verfahren zu seiner Herstellung
DE69418312D1 (de) * 1993-02-22 1999-06-10 Janssen Pharmaceutica Nv Aufheben der resistenz von hiv-1 linien gegenüber zidovudine
US5767310A (en) * 1993-03-19 1998-06-16 Merck & Co., Inc. Phenoxyphenylacetic acid derivatives
US5686478A (en) * 1993-07-20 1997-11-11 Merck & Co. Inc. Endothelin antagonists
GB9403408D0 (en) * 1994-02-23 1994-04-13 Wellcome Found Therapeutic benzonitriles
IL112739A0 (en) * 1994-02-23 1995-05-26 Wellcome Found Ayrlthiobenzonitrile compounds, their preparation and pharmaceutical compositions containing them
GB9403449D0 (en) * 1994-02-23 1994-04-13 Wellcome Found Therapeutic benzonitriles
US5559135A (en) * 1994-09-14 1996-09-24 Merck & Co., Inc. Endothelin antagonists bearing pyridyl amides
US5538991A (en) * 1994-09-14 1996-07-23 Merck & Co., Inc. Endothelin antagonists bearing 5-membered heterocyclic amides
EP0872233A1 (en) * 1997-04-14 1998-10-21 Janssen Pharmaceutica N.V. Antiretroviral compositions with improved bioavailability
RU2220950C2 (ru) * 1997-08-22 2004-01-10 Ф.Хоффманн-Ля Рош Аг N-алканоилфенилаланиновые производные
KR100686917B1 (ko) * 1998-06-19 2007-02-26 더 가번먼트 오브 더 유나이티드 스테이츠 오브 아메리카 레프리젠티드 바이 더 세크러터리, 디파트먼트 오브 헬쓰 앤드 휴먼 서비시즈 새로운 티올에스테르 및 그것의 이용
KR100820605B1 (ko) 1999-09-24 2008-04-08 얀센 파마슈티카 엔.브이. 항바이러스 조성물
AU2001277752A1 (en) * 2000-08-11 2002-02-25 Japan Tobacco Inc. Calcium receptor antagonists
ES2333802T3 (es) * 2004-04-23 2010-03-01 F. Hoffmann-La Roche Ag Inhibidores no nucleicos de transcriptasa inversa.
US7625949B2 (en) 2004-04-23 2009-12-01 Roche Palo Alto Llc Methods for treating retroviral infections
EP2061756B1 (en) * 2006-06-08 2013-09-25 Bristol-Myers Squibb Company 2-aminocarbonylphenylamino-2-phenilacetamides as factor viia inhibitors useful as anticoagulants
RU2449985C2 (ru) * 2010-03-31 2012-05-10 Федеральное государственное унитарное предприятие "Российский научный центр "Прикладная химия" Способ получения n,n-диметилацетамида
CN102675212B (zh) * 2012-05-09 2014-11-05 昆明理工大学 N-取代苯基-2-((1h-苯并咪唑-2-基)巯基)乙酰胺类衍生物及其用途
CN104000807B (zh) * 2014-05-28 2016-05-18 中山大学 苯基-酰胺类化合物在制备抗hiv-1病毒药物中的应用
CN105367437B (zh) * 2015-10-12 2017-08-01 湖北文理学院 一种2‑芳氨基乙酰胺类化合物的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1423430A (en) * 1973-03-29 1976-02-04 Wyeth John & Brother Ltd Thioamides
US4246429A (en) * 1978-06-23 1981-01-20 Janssen Pharmaceutica, N.V. Novel α-amino-phenylacetic acid derivatives
CH637828A5 (en) * 1978-11-15 1983-08-31 Koehler Franz Dr Chemie Kg Cytostatics
EP0620809B1 (en) * 1991-12-30 1997-03-05 Janssen Pharmaceutica N.V. $g(a)-SUBSTITUTED BENZENEMETHANAMINE DERIVATIVES

Also Published As

Publication number Publication date
AU8212091A (en) 1992-02-04
PT98259B (pt) 1998-12-31
US5556886A (en) 1996-09-17
DE69122963D1 (de) 1996-12-05
IE75693B1 (en) 1997-09-10
NO930047L (no) 1993-01-07
CA2084508A1 (en) 1992-01-11
CN1033142C (zh) 1996-10-30
ES2095942T3 (es) 1997-03-01
CZ279901B6 (cs) 1995-08-16
HU9300032D0 (en) 1993-04-28
MA22208A1 (fr) 1992-04-01
SK210291A3 (en) 1995-07-11
AP9100288A0 (en) 1991-07-31
OA09770A (fr) 1993-11-30
DZ1514A1 (fr) 2004-09-13
FI930070A0 (fi) 1993-01-08
RO112855B1 (ro) 1998-01-30
BG97265A (bg) 1994-03-24
LV10086A (lv) 1994-05-10
NO303777B1 (no) 1998-08-31
YU120491A (sh) 1994-06-10
RU2087465C1 (ru) 1997-08-20
SG48829A1 (en) 1998-05-18
PT98259A (pt) 1992-04-30
KR0183446B1 (ko) 1999-05-15
IL98756A0 (en) 1992-07-15
US5684049A (en) 1997-11-04
HU211873A9 (en) 1995-12-28
EP0538301B1 (en) 1996-10-30
NZ238763A (en) 1993-10-26
TW204337B (enExample) 1993-04-21
BG61809B1 (bg) 1998-06-30
EP0538301A1 (en) 1993-04-28
PH30977A (en) 1997-12-23
SI9111204A (en) 1995-04-30
MX9100100A (es) 1992-02-28
JPH05507931A (ja) 1993-11-11
LV10086B (en) 1995-02-20
DE69122963T2 (de) 1997-03-13
DK0538301T3 (da) 1996-11-25
IL98756A (en) 1996-06-18
ATE144765T1 (de) 1996-11-15
AU643056B2 (en) 1993-11-04
CS210291A3 (en) 1992-02-19
MY108580A (en) 1996-10-31
PL167076B1 (pl) 1995-07-31
NO930047D0 (no) 1993-01-07
HUT64013A (en) 1993-11-29
IL111924A0 (en) 1995-03-15
LT3602B (en) 1995-12-27
FI930070A7 (fi) 1993-01-08
HRP930485A2 (en) 1996-06-30
GR3021829T3 (en) 1997-02-28
CN1107835A (zh) 1995-09-06
PL297608A1 (enExample) 1992-07-13
SK279639B6 (sk) 1999-01-11
TNSN91056A1 (fr) 1992-10-25
IL111924A (en) 1996-12-05
AP311A (en) 1994-02-01
WO1992000952A1 (en) 1992-01-23
IE912208A1 (en) 1992-01-15
ZA915334B (en) 1993-03-31
LTIP848A (en) 1995-02-27
JPH0819068B2 (ja) 1996-02-28
CN1058958A (zh) 1992-02-26

Similar Documents

Publication Publication Date Title
CN1028990C (zh) 抑制人体免疫缺乏病毒的苯乙酰胺衍生物的制备方法
CN1230421C (zh) 酰胺化合物及其药物用途
CN1027588C (zh) N-苯烷基取代的α-氨基羧基酰胺衍生物的制备方法
CN1151133C (zh) 邻氨基苯甲酰胺及其用于制备药物的应用
CN1578767A (zh) 哌啶－2－酮衍生化合物及包含其作为活性成分的药学组合物
CN1305839C (zh) 苯基甘氨酸衍生物
CN1163484C (zh) 4-芳酰基-哌啶-ccr-3受体拮抗剂ⅲ
CN1197849C (zh) 作为基质金属蛋白酶抑制剂的2,3,4,5－四氢－1h－[1,4]苯并二氮杂草－3－异羟肟酸
CN1832928A (zh) 以5元杂环为基础的p38激酶抑制剂
CN1662509A (zh) 可用作激酶抑制剂的吡咯并三嗪苯胺化合物
CN1942443A (zh) 1,2－二氢吡啶化合物结晶及其制备方法
CN1727339A (zh) 三环化合物及其制备和用途
CN1030757A (zh) 苯并噻唑衍生物
CN1845921A (zh) 金刚烷和氮杂双环－辛烷及壬烷衍生物、其制备方法及其作为dpp－iv抑制剂的用途
CN1671695A (zh) 用作pde4抑制剂的吡咯烷二酮取代的哌啶－2,3－二氮杂萘酮化合物
CN1131214C (zh) 作为兴奋性氨基酸拮抗剂的四氢喹啉衍生物
CN1017049B (zh) 5，6-二氢-2-(取代的苯基)-1，2，4-三嗪-3，5(2h，4h)-二酮类化合物的制备方法
CN1681779A (zh) 4－吡咯烷基－苯基－苄基醚衍生物
CN1036064C (zh) 新的具有ngf生成促进活性的苯衍生物的制备方法
CN1720237A (zh) 3h－喹唑啉－4－酮衍生物
CN1649844A (zh) 异喹啉衍生物
CN1349542A (zh) 杂环化合物、其中间体和弹性蛋白酶抑制剂
CN1104017A (zh) 取代的(芳烷氧基苄基)氨基丙酰胺衍生物及其制备方法
CN1277820C (zh) 作为单胺氧化酶b的抑制剂的邻苯二甲酰亚氨基衍生物
CN1090282A (zh) 苯稠合羟基取代的环烷基和杂环化合物的磺酰胺衍生物

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee